NUTXNutex Health Inc.
Services-Business Services, NEC
- Revenue
- $875M
- 82% YoY
- Operating margin
- 31.5%
- 16% YoY
- EBITDA
- $296M
- 98% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -0.6×
- −$181M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear351% of net incomeCash flow under 80% of net income
- Dilutive SBCFired12% of revenueOver 10% of revenue
- Payouts exceed cash flowClear2% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear1% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $332M | $219M | $248M | $480M | $875M | 82% |
| Operating income | $170M | −$407M | −$32M | $131M | $276M | 111% |
| Net income | $133M | −$425M | −$46M | $52M | $71M | 36% |
| Operating cash flow | $173M | $51M | $1M | $23M | $248M | 972% |
| Capex | $37M | $15M | $9M | $2M | $3M | 9.6% |
| Stock-based comp | $4M | $190K | — | −$130K | $108M | 83176% |
| Buybacks | — | — | $0 | $0 | $5M |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $43K · 1
- Net
- −$43K
Pay vs performance
No pay-versus-performance disclosure yet.